東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

The carbonic anhydrases = current an...

Chegwidden, W. Richard.

Linked to FindBook

Google Book

Amazon

博客來

The carbonic anhydrases = current and emerging therapeutic targets /

Record Type:	Electronic resources : Monograph/item
Title/Author:	The carbonic anhydrases/ edited by W. Richard Chegwidden, Nicholas D. Carter.
Reminder of title:	current and emerging therapeutic targets /
other author:	Chegwidden, W. Richard.
Published:	Cham :Springer International Publishing : : 2021.,
Description:	xii, 288 p. :ill. (some col.), digital ;24 cm.
[NT 15003449]:	Dedication -- Preface -- The carbonic anhydrases in health and disease -- Carbonic anhydrase isozymes as diagnostic biomarkers and therapeutic targets -- Targeting carbonic anhydrases in vascular and pulmonary disease -- Carbonic anhydrase inhibitors in ophthalmology: glaucoma and macular oedema -- Targeting carbonic anhydrase isozymes in the treatment of neurological disorders -- Potential of carbonic anhydrase inhibitors in the treatment of oxidative stress and diabetes -- An overview of carbonic anhydrase-related neoplasms -- The carbonic anhydrase IX interactome and the regulation of cancer progression -- Carbonic anhydrase IX: current and emerging therapies -- Carbonic anhydrase inhibitors: designing isozyme-specific inhibitors as therapeutic agents -- Carbonic anhydrase inhibitors: identifying therapeutic cancer agents through virtual screening -- Targeting carbonic anhydrase IX in tumour imaging and theranostic cancer therapy.
Contained By:	Springer Nature eBook
Subject:	Carbonic anhydrase. -
Online resource:	https://doi.org/10.1007/978-3-030-79511-5
ISBN:	9783030795115

The carbonic anhydrases = current and emerging therapeutic targets /
The carbonic anhydrasescurrent and emerging therapeutic targets /[electronic resource] :edited by W. Richard Chegwidden, Nicholas D. Carter. - Cham :Springer International Publishing :2021. - xii, 288 p. :ill. (some col.), digital ;24 cm. - Progress in drug research,v. 752297-4555 ;. - Progress in drug research ;v. 75..

Dedication -- Preface -- The carbonic anhydrases in health and disease -- Carbonic anhydrase isozymes as diagnostic biomarkers and therapeutic targets -- Targeting carbonic anhydrases in vascular and pulmonary disease -- Carbonic anhydrase inhibitors in ophthalmology: glaucoma and macular oedema -- Targeting carbonic anhydrase isozymes in the treatment of neurological disorders -- Potential of carbonic anhydrase inhibitors in the treatment of oxidative stress and diabetes -- An overview of carbonic anhydrase-related neoplasms -- The carbonic anhydrase IX interactome and the regulation of cancer progression -- Carbonic anhydrase IX: current and emerging therapies -- Carbonic anhydrase inhibitors: designing isozyme-specific inhibitors as therapeutic agents -- Carbonic anhydrase inhibitors: identifying therapeutic cancer agents through virtual screening -- Targeting carbonic anhydrase IX in tumour imaging and theranostic cancer therapy.

This volume assembles and integrates the wealth of diverse information that is now accumulating in this burgeoning field. The existing and potential therapeutic applications of targeting CA cover a remarkably wide-range of diseases and disorders and have generated increasing and extensive interest in recent years. Its inter-disciplinary approach embraces both the most up-to-date therapeutic application of CA-targeting and the latest research data that will provide a platform for the development of novel applications. The interested audience comprises scientists and clinicians from many relevant disciplines within science and medicine.

ISBN: 9783030795115

Standard No.: 10.1007/978-3-030-79511-5doiSubjects--Topical Terms:

2055541
Carbonic anhydrase.

LC Class. No.: QP613.C37 / C37 2021

Dewey Class. No.: 612.01519

National Library of Medicine Call No.: QU 139

The carbonic anhydrases = current and emerging therapeutic targets /
LDR:02724nmm a2200349 a 4500 001 2253393
003 DE-He213
005 20211030111004.0
006 m d
007 cr nn 008maaau
008 220327s2021 sz s 0 eng d
020 $a 9783030795115 $q (electronic bk.)
020 $a 9783030795108 $q (paper)
024 7 $a 10.1007/978-3-030-79511-5 $2 doi
035 $a 978-3-030-79511-5
040 $a GP $c GP
041 0 $a eng
050 4 $a QP613.C37 $b C37 2021
060 4 $a QU 139
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 612.01519 $2 23
090 $a QP613.C37 $b C264 2021
245 0 4 $a The carbonic anhydrases $h [electronic resource] : $b current and emerging therapeutic targets / $c edited by W. Richard Chegwidden, Nicholas D. Carter.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a xii, 288 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Progress in drug research, $x 2297-4555 ; $v v. 75
505 0 $a Dedication -- Preface -- The carbonic anhydrases in health and disease -- Carbonic anhydrase isozymes as diagnostic biomarkers and therapeutic targets -- Targeting carbonic anhydrases in vascular and pulmonary disease -- Carbonic anhydrase inhibitors in ophthalmology: glaucoma and macular oedema -- Targeting carbonic anhydrase isozymes in the treatment of neurological disorders -- Potential of carbonic anhydrase inhibitors in the treatment of oxidative stress and diabetes -- An overview of carbonic anhydrase-related neoplasms -- The carbonic anhydrase IX interactome and the regulation of cancer progression -- Carbonic anhydrase IX: current and emerging therapies -- Carbonic anhydrase inhibitors: designing isozyme-specific inhibitors as therapeutic agents -- Carbonic anhydrase inhibitors: identifying therapeutic cancer agents through virtual screening -- Targeting carbonic anhydrase IX in tumour imaging and theranostic cancer therapy.
520 $a This volume assembles and integrates the wealth of diverse information that is now accumulating in this burgeoning field. The existing and potential therapeutic applications of targeting CA cover a remarkably wide-range of diseases and disorders and have generated increasing and extensive interest in recent years. Its inter-disciplinary approach embraces both the most up-to-date therapeutic application of CA-targeting and the latest research data that will provide a platform for the development of novel applications. The interested audience comprises scientists and clinicians from many relevant disciplines within science and medicine.
650 0 $a Carbonic anhydrase. $3 2055541
650 1 4 $a Pharmacology/Toxicology. $3 890953
650 2 4 $a Medical Biochemistry. $3 892387
650 2 4 $a Pharmacy. $3 636101
700 1 $a Chegwidden, W. Richard. $3 3521566
700 1 $a Carter, Nicholas D. $3 3521567
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Progress in drug research ; $v v. 75. $3 3521568
856 4 0 $u https://doi.org/10.1007/978-3-030-79511-5
950 $a Biomedical and Life Sciences (SpringerNature-11642)